ACHIEVE LIFE SCIENCES, INC. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Achieve Life Sciences, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2010 to Q3 2024.
  • Achieve Life Sciences, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 34.4M shares, a 62.6% increase year-over-year.
  • Achieve Life Sciences, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 19.8M shares, a 87.2% increase from 2022.
  • Achieve Life Sciences, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 10.6M shares, a 30.5% increase from 2021.
  • Achieve Life Sciences, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 8.12M shares, a 199% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 34.4M +13.2M +62.6% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 34.3M +15.3M +80.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 25M +7.13M +39.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 19.8M +9.23M +87.2% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 21.1M +11.4M +118% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 19M +9.4M +97.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 17.9M +8.46M +89.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 10.6M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 9.69M +242K +2.56% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 9.65M +2.26M +30.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 9.46M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q3 2021 9.45M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 7.39M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q3 2012 14.6M +4.88M +50.2% Jul 1, 2012 Sep 30, 2012 10-Q 2012-11-08
Q3 2011 9.74M +3.28M +50.9% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-08
Q2 2011 9.72M +3.32M +51.8% Apr 1, 2011 Jun 30, 2011 10-Q 2011-08-05
Q3 2010 6.45M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-03
Q2 2010 6.4M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.